Insider Transactions Reported by 17 Insiders of DELCATH SYSTEMS, INC.

Symbol
DCTH on Nasdaq
Location
Queensbury, NY

Insiders trading volume in the past year

DELCATH SYSTEMS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gil Aharon Director $47,360,631 15 May 2025
Steven A. J. Salamon Director $47,360,631 15 May 2025
Rosalind Advisors, Inc. Director $47,360,631 05 May 2025
Gerard J. Michel CHIEF EXECUTIVE OFFICER, Director $3,063,324 +$198,358 +6.9% 02 Mar 2026
Vojo Vukovic Chief Medical Officer $807,255 17 Feb 2026
Sandra Pennell Chief Financial Officer $696,242 +$50,018 +7.7% 06 Mar 2026
John Richard Sylvester Director $132,781 +$38,992 +42% 21 Nov 2025
John Purpura Chief Operating Officer $124,578 08 Feb 2023
Martha S. Rook Chief Operating Officer 17 Feb 2026
Christine Padula Interim Principal Accounting Officer 01 Sep 2021
Kevin Muir Gm Interventional Oncology 17 Feb 2026
David L. Hoffman Gen'l Counsel, Cco & Secy 17 Feb 2026
Elizabeth Czerepak Director 15 May 2025
Anthony Dias Vp Finance 08 Feb 2023
Roger G. Stoll PhD Director 23 May 2024
Johnny John Svp Clinical Dev & Med Affairs 08 Feb 2023
Bridget A. Martell Director 15 May 2025

Recent Insider Transactions by Companies or Individuals for DELCATH SYSTEMS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Sandra Pennell DCTH Common Stock Purchase 7.74% $50,018 $9.04 5,533 77,018 06 Mar 2026 Direct
Gerard J. Michel DCTH Common Stock Purchase 3.39% $100,309 $8.96 11,200 342,034 02 Mar 2026 Direct
David L. Hoffman DCTH Restricted Stock Units Award 28,250 28,250 17 Feb 2026 Direct
David L. Hoffman DCTH Stock Option (Right to Buy) Award 56,500 56,500 17 Feb 2026 Direct
Kevin Muir DCTH Restricted Stock Units Award 28,250 28,250 17 Feb 2026 Direct
Kevin Muir DCTH Stock Option (Right to Buy) Award 56,500 56,500 17 Feb 2026 Direct
Sandra Pennell DCTH Restricted Stock Units Award 28,250 28,250 17 Feb 2026 Direct
Sandra Pennell DCTH Stock Option (Right to Buy) Award 56,500 56,500 17 Feb 2026 Direct
Vojo Vukovic DCTH Restricted Stock Units Award 28,250 28,250 17 Feb 2026 Direct
Vojo Vukovic DCTH Stock Option (Right to Buy) Award 56,500 56,500 17 Feb 2026 Direct
Martha S. Rook DCTH Restricted Stock Units Award 28,250 28,250 17 Feb 2026 Direct
Martha S. Rook DCTH Stock Option (Right to Buy) Award 56,500 56,500 17 Feb 2026 Direct
Gerard J. Michel DCTH Restricted Stock Units Award 97,500 97,500 17 Feb 2026 Direct
Gerard J. Michel DCTH Stock Option (Right to Buy) Award 195,000 195,000 17 Feb 2026 Direct
John Richard Sylvester DCTH Common Stock Purchase 41.6% $38,992 $8.89 4,386 14,936 21 Nov 2025 Direct
Gerard J. Michel DCTH Common Stock Purchase 3.6% $98,049 $8.53 11,500 330,834 11 Nov 2025 Direct
Vojo Vukovic DCTH Common Stock Options Exercise 33.1% 42,000 168,882 12 Jun 2025 Direct
Vojo Vukovic DCTH Employee Stock Option (Right to Buy) Options Exercise -41.8% -42,000 58,500 12 Jun 2025 Direct
John Richard Sylvester DCTH Stock Option (right to buy) Award 22,500 22,500 15 May 2025 Direct
Steven A. J. Salamon DCTH Stock Option (right to buy) Award 22,500 22,500 15 May 2025 Direct
Elizabeth Czerepak DCTH Stock Option (right to buy) Award 22,500 22,500 15 May 2025 Direct
Gil Aharon DCTH Stock Option (right to buy) Award 22,500 22,500 15 May 2025 Direct
Bridget A. Martell DCTH Stock Option (right to buy) Award 22,500 22,500 15 May 2025 Direct
Aharon Gil DCTH Common shares Exercise of in-the-money or at-the-money derivative security 13.3% 400,000 3,413,468 05 May 2025 By Rosalind Advisors Inc., the advisor to the Rosalind Funds
Steven A. J. Salamon DCTH Common shares Exercise of in-the-money or at-the-money derivative security 13.3% 400,000 3,413,468 05 May 2025 By Rosalind Advisors Inc., the advisor to the Rosalind Funds
Rosalind Advisors, Inc. DCTH Common shares Exercise of in-the-money or at-the-money derivative security 13.3% 400,000 3,413,468 05 May 2025 By Rosalind Advisors Inc., the advisor to the Rosalind Funds
* An asterisk sign (*) next to the price indicates that the price is likely invalid.